The mecA gene is the central genetic element carried by all methicillin-resistant Staphylococcus aureus strains isolated to date. Differences in levels of antibiotic resistance (MICs) not only occurred through the transcription or translation of mecA but also were influenced by a variety of environmental factors and by a large number of chromosomal genes (the so-called auxiliary or fem genes), the primary functions of which have remained in most cases unidentified. Recently, a new Tn551 transposon library was constructed in the background of the highly resistant strain COL (MIC, 1,600 mg ⅐ ml Ϫ1 ), and mutants for which the methicillin MIC was reduced by at least 10-fold were selected (5) . One of them, RUSA315, expressed normal levels of penicillin-binding protein 2A (the mecA gene product), but the methicillin MIC for the mutant was drastically reduced (1.5 g ⅐ ml Ϫ1 ), and the mutant showed an abnormal cell wall composition characterized by the complete disappearance of the unsubstituted disaccharide-pentapeptide from the peptidoglycan (18) . The transposon insert in RUSA315 lies in the same gene as the mutation in strain 12F, a Tn551 mutant originally isolated by J. Kornblum and subsequently named femD (18) . While genetic crosses clearly implied that the gene altered in RUSA315 was essential for the expression of high-level methicillin resistance, the enzymatic nature of the gene product was not established. Cloning in Escherichia coli followed by sequencing located the Tn551 insert (⍀720) in an open reading frame provisionally called femR315 that theoretically codes for a protein of 451 amino acids. Interestingly, the amino acid sequence of FemR315 showed significant homology with that of the various phosphoglucomutases and phosphomannomutases found in databases (18) . In fact, the best scores were observed with the product of the recently identified E. coli gene glmM (12) , the first phosphoglucosamine mutase characterized to date. GlmM has been shown to catalyze the formation of glucosamine-1-phosphate from glucosamine-6-phosphate, the first step in the biosynthetic pathway leading to the essential peptidoglycan precursor UDP-N-acetylglucosamine (12, 17) . Since the effects of the femR315 mutation on the composition of S. aureus peptidoglycan were consistent with the involvement of FemR315 in such a metabolic step, the function of FemR315 was investigated in that way. We report here that the staphylococcal femR315 gene can fully complement a well-characterized glmM deficiency in E. coli and that the overproduced FemR315 enzyme purified to homogeneity shows the expected phosphoglucosamine mutase activity.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The E. coli strains used in this work were as follows: . The selective markers used for the plasmids were as follows: ampicillin for pTrc99A, pMLJ1, and pQE-8; chloramphenicol for pGMM; and kanamycin for pREP4. Plasmid pSW-4A carrying a 2.2-kb S. aureus chromosomal fragment including the femR315 gene has been previously described (18) , and the pTrc99A cloning vector was purchased from Pharmacia (Uppsala, Sweden). Unless otherwise noted, 2YT (13) was used as a rich medium for growing cells. Growth was monitored at 600 nm with a spectrophotometer (model 240; Gilford Instrument Laboratories, Inc., Oberlin, Ohio). For strains carrying drug resistance genes, antibiotics were used at the following concentrations (in micrograms per milliliter): 100 for ampicillin, 30 for kanamycin, and 25 for chloramphenicol.
General DNA techniques and E. coli cell transformation. Small-and largescale plasmid isolations were carried out by the alkaline lysis method. Standard procedures for endonuclease digestions, ligation, and agarose electrophoresis (15) were used. E. coli cells were made competent and transformed with plasmid DNA either by the method of Dagert and Ehrlich (3) or by electroporation.
Complementation test. Cells of the thermosensitive mutant strain GPM83 were made competent as described above and transformed by the various plasmids to be tested. The cell suspension mixed with plasmid DNA was kept on ice for 4 h before being heated for 3 min at 42°C. Then, 400 ml of 2YT medium was added and the cells were incubated at 30°C for 2 h. Aliquots from the final suspensions were plated onto two 2YT-ampicillin plates, one of which was incubated at 30°C and the other of which was incubated at 42°C. Growth was observed after 24 h of incubation.
Construction of plasmids. A plasmid suitable for high-level overproduction of FemR was constructed as follows. PCR primers were designed to incorporate an NcoI site (in boldface type) 5Ј to the initiation codon (underlined) of femR315 (5Ј-TAAACCATGGGAAAATATTTTGGT-3Ј) and a BamHI site (in boldface type) 3Ј to the gene after the stop codon (5Ј-CACAAGGATCCGATGCAT ACGCATCGGCTC-3Ј). These primers were used to amplify the femR315 gene from plasmid pSW-4A. The resulting material was treated with NcoI and BamHI and ligated between the corresponding sites of vector pTrc99A. The ligation mixture was then used to transform by electroporation strain GPM83, and clones were selected for both ampicillin resistance and growth at 42°C. All transformants isolated in this way carried the expected plasmid named pMLJ2, allowing expression of the femR315 gene under the control of the strong IPTG (isopropyl-␤-D-thiogalactopyranoside)-inducible trc promoter. As shown by their sensitivity to chloramphenicol, all these clones have lost the plasmid pGMM initially present in strain GPM83, a plasmid whose replication is thermosensitive and which carries the glmM gene from E. coli (12) . The clones consequently expressed FemR315 as the sole source of phosphoglucosamine mutase activity. One of these clones, named FEMR831, was used for further experiments.
Isolation of sacculi and quantitation of peptidoglycan. Exponential-phase cells (0.5-liter cultures) of JM83 or FEMR831 were grown at 37°C in 2YT medium. When the optical density of the culture reached 0.7 (about 3 ϫ 10 8 cells ⅐ ml
Ϫ1
), cells were harvested in the cold, washed with a cold 0.9% NaCl solution, and rapidly suspended by vigorous stirring in 20 ml of a hot (95 to 100°C) aqueous 4% sodium dodecyl sulfate (SDS) solution for 30 min. After standing overnight at room temperature, the suspensions were centrifuged for 30 min at 200,000 ϫ g in a Beckman TL100 centrifuge and the pellets were washed several times with water. Final suspensions made in 2 ml of water were homogenized by brief sonication. Aliquots were hydrolyzed and analyzed as previously described, and the peptidoglycan content of the sacculi was expressed in terms of its muramic acid content (9) .
Preparation of crude enzyme. Cells of JM83 or FEMR831 (0.5-liter cultures) were grown exponentially as described above. When the optical density of the culture reached 0.2, IPTG was added when required at a final concentration of 0.1 mM and growth was continued for 2 h. Cells of the thermosensitive mutant strain GPM83 were grown at 30°C, or first at 30°C and then for 5 h at the restrictive temperature of 42°C, as previously described (12) . In all cases, harvested cells were washed with 40 ml of cold 0.02 M potassium phosphate buffer (pH 7) containing 1 mM ␤-mercaptoethanol. The wet cell pellet was suspended in 5 ml of the same buffer and disrupted by sonication (Sonicator 150; T. S. Ultrasons, Annemasse, France) for 5 min with cooling. The resulting suspension was centrifuged at 4°C for 30 min at 200,000 ϫ g. The supernatant was dialyzed overnight at 4°C against 100 volumes of the same phosphate buffer, and the resulting solution (5 ml, 10 to 12 mg of protein ⅐ ml Ϫ1 ) designated as crude enzyme was stored at Ϫ20°C. SDS-polyacrylamide gel electrophoresis (PAGE) analysis of proteins was performed as previously described with 12% polyacrylamide gels (8) . Protein concentrations were determined by the method of Bradford (1) with bovine serum albumin as the standard.
Purification of the FemR315 protein (six His tagged). The PCR fragment of femR315 was ligated into the QIAexpress SRF vector pQE-8 (Qiagen Inc., Chatsworth, Calif.) to obtain a six-His-protein fusion (type IV construct; Nterminal His tag). The recombinant plasmid (pQESW-2) was transferred into E. coli M15 containing the repressor plasmid pREP4. This transformant can produce the six-His-FemR315 fusion protein at a high level when it is induced with IPTG (data not shown). A one-step purification procedure of recombinant FemR315 was carried out under native conditions, basically by following the steps in the manufacturer's guidelines: growth and induction (IPTG) of the culture; preparation of cell lysate by sonication; binding of six His-FemR315 on Ni-nitrilotriacetic acid resin and washing with wash buffer (50 mM sodium phosphate [pH 6.0], 0.3 M NaCl, 10% glycerol) to remove impurities; elution of six His-FemR315 with 0.5 M imidazole added to the wash buffer; and diafiltration of six-His-FemR315 eluate with 0.1 M sodium phosphate buffer (pH 7.2). The six His-FemR315 prepared in this manner was 80 to 90% pure, as estimated by SDS-PAGE (data not shown). For storage, the purified protein was mixed with 25% glycerol and kept at Ϫ20°C at a concentration of 1.27 mg ⅐ ml
. Assay for phosphoglucosamine mutase activity. A coupled assay in which the glucosamine-1-phosphate synthesized from glucosamine-6-phosphate by the mutase was quantitatively converted to UDP-N-acetylglucosamine in the presence of purified bifunctional GlmU enzyme (10, 11) was routinely used. The standard assay mixture contained 50 mM Tris-HCl buffer (pH 8.0), 3 mM MgCl 2 , 1 mM glucosamine-6-phosphate, 0.4 mM [ 14 C]acetyl coenzyme A ([ 14 C]acetyl-CoA; 700 Bq), 10 mM UTP, 0.3 mM glucose-1,6-diphosphate, pure GlmU enzyme (1 mg), and enzyme (0.1 to 10 mg of protein, depending on overexpression or purification factors) in a final volume of 100 ml. Mixtures were incubated at 37°C for 30 min, and reactions were terminated by the addition of 10 ml of acetic acid. Reaction products were separated by high-voltage electrophoresis on Whatman 3MM filter paper in 2% formic acid (pH 1.9) for 90 min at 40 V/cm with an LT36 apparatus (Savant Instruments, Hicksville, N.Y.). The only two radioactive spots (acetyl-CoA and UDP-N-acetylglucosamine) were located by overnight autoradiography with type R2 films (3M, St. Paul, Minn.) or with a radioactivity scanner (Multi-Tracermaster LB285; Berthold France, Elancourt, France). Radioactive spots were cut out and counted in an Intertechnique SL 30 liquid scintillation spectrophotometer with a solvent system consisting of 2 ml of water and 13 ml of Aqualyte mixture (J. T. Baker Chemicals, Deventer, The Netherlands).
Chemicals.
) was purchased from ICN (Irvine, Calif.). Glucosamine-1-phosphate, glucosamine-6-phosphate, glucose-1,6-diphosphate, UTP, and UDP-N-acetylglucosamine were from Sigma Chemical Co. (St. Louis, Mo.).
RESULTS AND DISCUSSION
The S. aureus femR315 gene complements an E. coli glmM mutation. A search in protein databases for homologs of the S. aureus femR315 gene product identified a large series of enzymes, such as phosphoglucomutase, phosphomannomutase, and similar enzymes capable of catalyzing the isomerization of hexose and hexosamine phosphates (18) . The highest degree of similarity was with the E. coli glmM gene product (44% identity on 445 amino acids) (Fig. 1) , the first bacterial phosphoglucosamine mutase identified to date (12) , which catalyzes the synthesis of glucosamine-1-phosphate from glucosamine-6-phosphate, the initial step in the reaction sequence leading to the formation of the essential peptidoglycan precursor UDP-N-acetylglucosamine. Considering the effects on peptidoglycan composition and methicillin resistance in methicillin-resistant S. aureus strains that resulted from alterations of the femR315 gene, it was proposed that the phenotype of the RUSA315 mutant was related to some abnormality in or deficit of UDP-
FIG. 1. Alignment of the predicted amino acid sequence of S. aureus FemR315 (FEMR.SAURE) with that of previously identified GlmM enzymes from E. coli (GLMM.ECOLI), Haemophilus influenzae (GLMM.HAEIN), and
Helicobacter pylori (GLMM.HELPY). The alignments were performed with the Clustal W program (16) . Asterisks indicate amino acid residues conserved in all sequences, and dots indicate similar residues. The consensus amino acid sequence of hexose phosphate mutases is underlined, and the putative phosphorylated serine residue is indicated by an arrow.
N-acetylglucosamine metabolism (18) . It was thus tempting to speculate that the femR315 gene also encoded a phosphoglucosamine mutase.
To test this hypothesis, the E. coli glmM mutant strain GPM83 was used to see whether FemR315 could compensate for a GlmM deficiency. This strain, derived from JM83, carried an inactivated copy of glmM on the chromosome and a wildtype copy on a thermosensitive plasmid (pGMM) derived from pMAK705 (12) . Strain GPM83 was first transformed by plasmid pSW-4A, a plasmid carrying a 2.2-kb chromosomal insert from S. aureus including the femR315 gene under the control of its own promoter (18) . Unfortunately, transformants failed to grow at the restrictive temperature of 42°C, but this negative result might be interpreted in two different manners: (i) the femR315 gene does not encode a phosphoglucosamine mutase and (ii) FemR315 is a GlmM protein, but its expression from the pSW-4A plasmid was too low for specific cell requirements.
To answer the question of why transformants failed to grow at the restrictive temperature, the femR315 gene sequence was amplified by PCR from plasmid pSW-4A and cloned under the control of the strong IPTG-inducible trc promoter in the expression vector pTrc99A. The resulting plasmid, pMLJ2, was shown to complement the thermosensitivity of strain GPM83 even in the absence of IPTG, a result indicating that the basal expression of FemR315 (due to an incomplete repression of the plasmid lacI q gene) from this new construct was enough to ensure normal cell growth. As judged by the loss of chloramphenicol resistance, the pGMM plasmid was effectively cured from these clones during growth at the restrictive temperature. Consequently, these transformants (named FEMR831) now expressed femR315 as the sole source of phosphoglucosamine mutase activity, an interesting genetic background for further investigations of the function of FemR315 in vivo. Finally, the peptidoglycan contents of exponentially growing FEMR831 and JM83 cells were determined and appeared quite similar (10,000 and 11,500 nmol per g of bacterial dry weight, respectively), demonstrating that the complementation of the glmM defect of strain GPM83 by the pMLJ2 plasmid was complete.
Overproduction of FemR315 phosphoglucosamine mutase in E. coli. The specific activity of phosphoglucosamine mutase was determined in E. coli FEMR831, which carries an inactivated copy of the glmM gene in the chromosome and the S. aureus femR315 gene on the multicopy plasmid pMLJ2. As shown in Fig. 2 , FEMR831 cells induced with 0.1 mM IPTG accumulated large amounts of a protein species of about 50 kDa, a value which was consistent with that (49,180 kDa) calculated from the DNA sequence of femR315 (18) . As soon as 1 h after induction, FemR315 made up about 20% of total cell proteins. A typical fractionation procedure of cell extracts showed that FemR315 was found mainly in the soluble fraction, but significant amounts (20 to 30%) of the overproduced protein were also detected in the particulate fraction as inclusion bodies (data not shown). Induction with more than 0.2 mM IPTG was precluded, since FemR315 aggregated under these conditions, as was confirmed by the presence of multiple inclusion bodies in the bacteria.
As shown in Table 1 , the overproduction of FemR315 in E. coli cells was correlated with an increase of phosphoglucosamine mutase activity. The S. aureus phosphoglucosamine mutase activity that could be detected in noninduced FEMR831 cells was relatively low, representing approximately 30% of the wild-type GlmM activity. Nevertheless, as described above, this basal expression of FemR315 from the pMLJ2 plasmid was sufficient to complement a thermosensitive glmM mutant strain. When they were induced with IPTG, FEMR831 cells contained fivefold more phosphoglucosamine mutase activity than wild-type JM83 cells. This is a significant but moderate overproduction factor that might be explained in different ways: (i) GlmM may be a relatively abundant protein in E. coli which may normally account for 0.5 to 1% of total cell proteins and which consequently may not be overproduced by a factor exceeding 40 to 50 (12) and (ii) a limit to the extent of 
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a Cells were grown in 2YT medium at 30°C, 37°C, or, in the case of strain GPM83, first at 30°C and then for 5 h at 42°C (nonpermissive temperature), the time at which the growth rate of the thermosensitive glmM mutant strain began to decrease (12) . When required, IPTG was added at a final concentration of 0.1 mM and growth was continued for 2 h.
b Glucose-1,6-diphosphate was added in the in vitro assay.
FemR315 overproduction in E. coli cells may have been imposed because this protein has a tendency to aggregate at high levels of expression. Also, the kinetic parameters of the GlmM and FemR315 phosphoglucosamine mutases have not yet been precisely determined, and eventual differences between the turnover numbers of these enzymes should be taken into consideration for a correct estimation of the overproduction factor. As previously observed, the level of the E. coli GlmM enzyme that could be detected in the mutant GPM83 cells after growth for 5 h at the restrictive temperature was about 40-fold lower than in JM83 cells (Table 1 and reference 12) . When compared to the GPM83 genetic background, an overall overproduction factor of more than 200 could thus be estimated for the S. aureus phosphoglucosamine mutase in induced FEMR831 cells. A rapid one-step purification of the FemR315 enzyme was performed by using the His tag fusion procedure. As shown in Table 1 , the pure six-His-FemR315 protein (0.5 to 5 g) effectively carried the expected phosphoglucosamine activity. The specific activity of the fusion protein was more or less equivalent to that determined with FEMR831 cells induced with IPTG, in which the overproduced wild-type FemR315 enzyme represented about 20 to 30% of cell proteins (see above), suggesting that the fusion protein was about threefold less active than the wild-type enzyme.
S. aureus FemR315 is a new member of the GlmM family. All these results taken together supported the conclusion that FemR315 is a new member of the little family of confirmed bacterial phosphoglucosamine mutases which until now included only the glmM gene products from E. coli (also named yhbF or mrsa) (4, 12) and Haemophilus influenzae (mrsa) (7) . Most recently, the Helicobacter pylori ureC gene product was also identified as a phosphoglucosamine mutase (2, 6) . A high degree of sequence similarity was already noted earlier between FemR315 and UreD from Mycobacterium leprae (65% similarity in 462 amino acids) and UreC from Helicobacter pylori (61% similarity in 444 amino acids) (18) . All of these gene products contain in their amino acid sequences the characteristic signatures of hexosephosphate mutases (Fig. 1) . These motifs include the putative serine residue (S102 in FemR315) whose phosphorylation is a prerequisite for enzyme activity. Because of the similarity of its reaction mechanism to that of the well-characterized phosphoglucomutase (14) , glucosamine-1,6-diphosphate should be an intermediate in the catalytic process of phosphoglucosamine mutases. It is presently unknown whether this compound or another hexose-1,6-diphosphate also ensures the initial activation (phosphorylation) of the enzyme in vivo, a question still open when we consider the possibility that glucose-1,6-diphosphate (the only hexose-diphosphate commercially available) plays this role on FemR315 in vitro ( Table 1) . As previously observed with E. coli GlmM (12) , only a small part of the overproduced S. aureus FemR315 enzyme that could be extracted from FEMR831 cells was found in a phosphorylated (active) form (Table 1 ). This basal level was greatly enhanced (up to 100-fold) by increasing the concentration of glucose-1,6-diphosphate in the in vitro assay. The same was observed with the purified six-His-FemR315 enzyme, which appeared to be partially phosphorylated and was readily activated by the diphosphate compound (Table 1) .
The nature of the phosphoglucosamine mutase activity expressed in mutant RUSA315 and the exact mechanism of reduction in methicillin resistance in the mutant remain to be determined. The in-frame insertion of Tn551 may have interrupted transcription of the open reading frame, causing an abnormality of transcription or a gene product of reduced catalytic activity. The transposon insertion site (⍀720) in mutant RUSA315 was previously determined to be 1,077 bp from the initiation codon and 272 bp from the termination codon of the femR315 gene (18) . Interestingly, another mutant of similar phenotype, strain RUSA12F, was shown to be altered in the same gene and the Tn551 insertion site (⍀558) was located approximately 50 bp upstream from that of ⍀720 in RUSA315 (5, 18) . FemR315 proteins lacking 90 to 100 amino acid residues in the C-terminal region are expected to be produced in the RUSA315 and RUSA12F mutant strains. These truncated proteins still contain the characteristic signatures of phosphohexomutases and may thus retain some enzymatic activity, at least enough to sustain viability and the slow growth of RUSA315 and RUSA12F mutant cells. Alteration of the femR315 gene most probably results in a reduced availability of UDP-N-acetylglucosamine for peptidoglycan synthesis. Reduction in the pool size of cell wall precursors may then favor the interaction of penicillin-binding protein 2A with methicillin, causing a reduction in the MIC observed for the mutant RUSA315 (5).
